BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 1999
View Archived Issues
Photogen achieves favorable preliminary results with ocular melanoma treatment
Read More
Company Profile: Endorex
Read More
New bone marrow transplant technique looks promising
Read More
Stem cells provide lineage for liver cells, according to U. of Pittsburgh study
Read More
NeoTherapeutics' lead compound ameliorates AD
Read More
LifeTime and Dovetail enter exclusive agreement for Beta LT anticancer compound
Read More
Inhibitex obtains license to MSCRAMM from University of Minnesota
Read More
Roche and Sangamo sign Universal GeneTools research agreement
Read More
Cytran's IM-862 awarded antiangiogenesis patent
Read More
Atrix completes phase I clinical trial for prostate cancer therapy
Read More
EULAR meeting highlights: overview of clinical experience with Reumacon
Read More
Abbott and Triangle enter worldwide marketing alliance for antiviral products
Read More
HIV protease inhibitors from Abbott with potent antiviral activity
Read More
Bristol-Myers Squibb patents new paclitaxel-derived antitumor agents
Read More
Potent, orally active antiplatelet fibrinogen antagonists in early development at Ortho-McNeil
Read More
Merck Frosst investigates alternatives to conventional NSAIDs
Read More
D2E7 plus methotrexate: a safe and effective treatment for rheumatoid arthritis
Read More
Small-molecule inhibitors of proinflammatory cytokines developed at Boehringer Ingelheim
Read More
Japanese advisory committee recommends approval of class III antiarrhythmic
Read More
Lilly's new 5-ht1f agonists especially useful for migraine
Read More
European Commission issues first approval for tasonermin
Read More
Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders
Read More
Antifibroproliferative agents emerge from FibroGen/Zeneca collaboration
Read More
Policosanol in patients with hyperlipidemia and coronary risk factors
Read More
Two U.S. patents licensed to Aastrom broaden coverage for cell therapy technologies
Read More
CoCensys granted patent for noncompetitive AMPA receptor antagonists and their use
Read More
First new narcolepsy agent in four decades introduced in Canada
Read More
Pyrisulfoxins: new antibiotics isolated and tested for antileukemic activity
Read More
Elevated troponin T levels predict beneficial response to abciximab in unstable angina
Read More